276 related articles for article (PubMed ID: 26583705)
1. Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.
Kang CS; Wu N; Chen Y; Sun X; Bandara N; Liu D; Lewis MR; Rogers BE; Chong HS
J Inorg Biochem; 2016 Jan; 154():60-6. PubMed ID: 26583705
[TBL] [Abstract][Full Text] [Related]
2. Promising bifunctional chelators for copper 64-PET imaging: practical (64)Cu radiolabeling and high in vitro and in vivo complex stability.
Wu N; Kang CS; Sin I; Ren S; Liu D; Ruthengael VC; Lewis MR; Chong HS
J Biol Inorg Chem; 2016 Apr; 21(2):177-84. PubMed ID: 26666778
[TBL] [Abstract][Full Text] [Related]
3. Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development.
De Silva RA; Jain S; Lears KA; Chong HS; Kang CS; Sun X; Rogers BE
Nucl Med Biol; 2012 Nov; 39(8):1099-104. PubMed ID: 22743158
[TBL] [Abstract][Full Text] [Related]
4. Novel (64)Cu-radiolabeled bile acid conjugates for targeted PET imaging.
Chong HS; Chen Y; Kang CS; Sun X; Wu N
Bioorg Med Chem Lett; 2015 Mar; 25(5):1082-5. PubMed ID: 25661712
[TBL] [Abstract][Full Text] [Related]
5. New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging.
Gai Y; Sun L; Hui W; Ouyang Q; Anderson CJ; Xiang G; Ma X; Zeng D
Inorg Chem; 2016 Jul; 55(14):6892-901. PubMed ID: 27347690
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and radiopharmacological evaluation of ⁶⁴Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator.
Bergmann R; Ruffani A; Graham B; Spiccia L; Steinbach J; Pietzsch J; Stephan H
Eur J Med Chem; 2013; 70():434-46. PubMed ID: 24184988
[TBL] [Abstract][Full Text] [Related]
7. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators.
David T; Hlinová V; Kubíček V; Bergmann R; Striese F; Berndt N; Szöllősi D; Kovács T; Máthé D; Bachmann M; Pietzsch HJ; Hermann P
J Med Chem; 2018 Oct; 61(19):8774-8796. PubMed ID: 30180567
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
Cooper MS; Ma MT; Sunassee K; Shaw KP; Williams JD; Paul RL; Donnelly PS; Blower PJ
Bioconjug Chem; 2012 May; 23(5):1029-39. PubMed ID: 22471317
[TBL] [Abstract][Full Text] [Related]
9. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
10. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ
Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
Ait-Mohand S; Fournier P; Dumulon-Perreault V; Kiefer GE; Jurek P; Ferreira CL; Bénard F; Guérin B
Bioconjug Chem; 2011 Aug; 22(8):1729-35. PubMed ID: 21761921
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J
Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436
[TBL] [Abstract][Full Text] [Related]
14. Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with
Chong HS; Chen Y; Kang CS; Sin I; Zhang S; Wang H
J Inorg Biochem; 2021 Aug; 221():111436. PubMed ID: 33971521
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector.
Läppchen T; Kiefer Y; Holland JP; Bartholomä MD
Nucl Med Biol; 2018 May; 60():45-54. PubMed ID: 29571066
[TBL] [Abstract][Full Text] [Related]
16. Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging.
Kang CS; Ren S; Sun X; Chong HS
ChemMedChem; 2016 Oct; 11(19):2188-2193. PubMed ID: 27624789
[TBL] [Abstract][Full Text] [Related]
17. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
Bailey GA; Price EW; Zeglis BM; Ferreira CL; Boros E; Lacasse MJ; Patrick BO; Lewis JS; Adam MJ; Orvig C
Inorg Chem; 2012 Nov; 51(22):12575-89. PubMed ID: 23106422
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
20. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
